Clinical Trials Logo

Clinical Trial Summary

Postmastectomy radiotherapy (PMRT) is unequivocally beneficial in reducing the recurrences as well as improving survival in node positive breast cancer patients. PMRT for women with T1-T2 tumors and negative axillary nodes is not generally warranted because of the presumed low risk of recurrence in this population as a whole. However, in the setting of multiple adverse prognostic factors, the recurrence risk approaches and in some cases surpasses the risk of recurrence documented for patients with one to three positive lymph nodes. Numerous retrospective series have reported the outcome and patterns of failure for post-mastectomy patients treated without radiation. Many of these series have analyzed several high risk factors which were predictive of loco-regional recurrence wherein the role of adjuvant post-mastectomy radiation can be considered. Some authors have used combinations of prognostic factors, such as age, tumour size, grade, receptor status, Her2neu status and lympho-vascular space invasion to define subgroups with more specific risks of loco-regional recurrence than single factors alone. The current trial hypothesizes that "Post-mastectomy radiation in high risk, node negative early breast cancer patients decreases rates of loco-regional recurrence and improves disease free survival" and propose to address the question in randomized setting.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02992574
Study type Interventional
Source Tata Memorial Centre
Contact Tabassum Wadasadawala, MBBS,MD,DNB
Phone 02227405078
Email twadasadawala@actrec.gov.in
Status Recruiting
Phase N/A
Start date May 27, 2016
Completion date December 2033

See also
  Status Clinical Trial Phase
Completed NCT02944604 - The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy Phase 4
Completed NCT03012152 - A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction N/A
Terminated NCT04168957 - An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007 Phase 1
Recruiting NCT02967146 - Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer Phase 3
Completed NCT02958332 - Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer N/A
Completed NCT03030677 - Establishing Technique for PECS2 Catheter Insertion N/A
Completed NCT03165955 - A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients Phase 1
Completed NCT03066947 - SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer Phase 1/Phase 2
Completed NCT02964234 - Empowering Latinas to Obtain Breast Cancer Screenings N/A
Completed NCT02996240 - Breast, Omega 3 Free Fatty Acid, Ph 0 N/A
Completed NCT03010371 - Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors. N/A
Completed NCT02209857 - The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy N/A
Completed NCT03014076 - Immunotherapy Vaccine and Herceptin in Breast Cancer Phase 1
Terminated NCT02975128 - Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance N/A
Active, not recruiting NCT03121248 - Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years N/A
Active, not recruiting NCT02997384 - Feasibility of Breast Cancer Risk Evaluation in Women From the General Population N/A
Completed NCT03012893 - Identification of C7; Evaluations of 2 Sonographic Methods Using a Transverse and a Sagittal Scan. N/A
Completed NCT03023007 - Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy N/A
Completed NCT04993040 - A PK Study of Oraxol in Breast Cancer Patients Phase 1
Completed NCT02992067 - CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer